Free shipping on all orders over $ 500

Vortioxetine hydrobromide

Cat. No. M2134
Vortioxetine hydrobromide Structure
Synonym:

Lu AA21004

Size Price Availability Quantity
10mg USD 50  USD50 In stock
50mg USD 100  USD100 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vortioxetine hydrobromide is a novel multimodal antidepressant and a 5-HT transporter (5-HTT) inhibitor in vitro. Vortioxetine (Lu AA21004) inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Vortioxetine significantly increased cell proliferation and cell survival and stimulated maturation of immature granule cells in the subgranular zone of the dentate gyrus of the hippocampus after 21 days of treatment. Vortioxetine enhances contextual and episodic memory in rat behavioral models. Vortioxetine (Lu AA21004) displays an antidepressant and anxiolytic profile following repeated administration associated with increased neurogenesis at several stages.

Chemical Information
Molecular Weight 379.36
Formula C18H22N2S.HBr
CAS Number 960203-27-4
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Guilloux JP, et al. Neuropharmacology. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.

[2] Mahableshwarkar AR, et al. Curr Med Res Opin. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.

[3] Bang-Andersen B, et al. J Med Chem. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

Related 5-HT Receptor Products
TC-2153

TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP). TC-2153 also inhibits 5-HT2A receptor-mediated signaling.

Gentisein

Gentisein (NSC-329491), the major metabolite of Mangiferin, shows the most potent serotonin uptake inhibition with an IC50 value of 4.7 µM.

MM120

MM120 is a synthetic tryptamine that is also a partial agonist at the 5-hydroxytryptamine 2A (5-HT2A) receptor. It can be used in studies related to GAD and attention deficit hyperactivity disorder (ADHD).

SB 258741 hydrochloride

SB 258741 hydrochloride is a specific 5-HT7 receptor antagonist for schizophrenia.

5-HT1A antagonist 1

5-HT1A antagonist 1 is a potent and selective 5-HT1A receptor antagonist with a Ki value of 35 nM.5-HT1A antagonist 1 can be used in the study of central nervous system disorders.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vortioxetine hydrobromide, Lu AA21004 supplier, 5-HT Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.